A significant loss or theft of a drug precursor shall be reported in writing to the Board of Pharmacy. "Significant loss" includes suspected diversions, in-transit losses or any other unexplained loss.

[03-07-80...08-27-90; 16.19.21.22 NMAC - Rn, 16 NMAC 19.21.22, 03-30-02]